With the way the Company is currently bleeding cash will it still be around to take advantage of the increased prices in 2016 and beyond? That's my current concern....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025